Alena Fowler’s Post

🌟 At AstraZeneca , we're not just advancing medicine; we're transforming lives. By integrating #AI with home spirometry, we aim to bring early diagnosis and monitoring of respiratory diseases right to your doorstep. It's innovation with purpose.💡 #RespiratoryHealth #AIInnovation

🌟 At AstraZeneca , we're not just advancing medicine; we're transforming lives. By integrating #AI with home spirometry, we aim to bring early diagnosis and monitoring of respiratory diseases right to your doorstep. It's innovation with purpose.💡 #RespiratoryHealth #AIInnovation

🌟 At AstraZeneca , we're not just advancing medicine; we're transforming lives. By integrating #AI with home spirometry, we aim to bring early diagnosis and monitoring of respiratory diseases right to your doorstep. It's innovation with purpose.💡 #RespiratoryHealth #AIInnovation

The latest breakthrough research from the ISAR, as detailed in the recent publication "International Variation in Severe Exacerbation Rates in Patients With Severe Asthma” in CHEST, has unveiled an interesting landscape of variability in severe asthma exacerbation rates across diverse countries. Read the full press release: https://lnkd.in/ezM-R7Am Read the full article here: https://lnkd.in/eYWZfQDc #ResearchInRealLife #SevereAsthma #Asthma #Research

The latest breakthrough research from the ISAR, as detailed in the recent publication "International Variation in Severe Exacerbation Rates in Patients With Severe Asthma” in CHEST, has unveiled an interesting landscape of variability in severe asthma exacerbation rates across diverse countries. Read the full press release: https://lnkd.in/ezM-R7Am Read the full article here: https://lnkd.in/eYWZfQDc #ResearchInRealLife #SevereAsthma #Asthma #Research

The latest breakthrough research from the ISAR, as detailed in the recent publication "International Variation in Severe Exacerbation Rates in Patients With Severe Asthma” in CHEST, has unveiled an interesting landscape of variability in severe asthma exacerbation rates across diverse countries. Read the full press release: https://lnkd.in/ezM-R7Am Read the full article here: https://lnkd.in/eYWZfQDc #ResearchInRealLife #SevereAsthma #Asthma #Research

👏Great news! Submission deadline extended to 26 July 2024! Welcome more submissions! 💡 Special Issue "Diagnosis and Management of Chronic Obstructive Pulmonary Disease (#COPD) ", led by Dr. Juan Luis Rodriguez Hermosa. 🧐The aim of this Special Issue is to gather articles focused on improving the diagnosis of COPD, as well as advances in the treatment of this disease, which consider both pharmacological and non-pharmacological interventions. 📨Website and submission link: https://lnkd.in/gBRjwBke #ChronicObstructivePulmonaryDisease #Pulmonary #lung #COPD #treatment #diagnosis #pharmacological Journal of Clinical Medicine (JCM) MDPI

Today is #WorldAsthmaDay, organized by Global Initiative for Asthma. Asthma affects over 260m people globally, about 3% of the population! VIDA is proud to provide quantitative imaging analysis for #SARP and many commercial clinical trials, with a goal to accelerate the approval of new therapies to those suffering with asthma. If you missed our webinar with pulmonologist and asthma luminary Mario Castro, MD, here are some highlight clips: https://hubs.la/Q02wphpG0 #asthma #digitalbiomarkers

🫁 Predicting mortality in patients with severe acute respiratory distress syndrome on #ECLS? PREDICT VV-ECMO score, including 5 easy-to-access parameters: ⏳ age 🫁 lung fibrosis 🪫 immunosuppression 💦 cumulative fluid balance 💨 sweep gas flow on day 3 reported here as first model to predict probability of hospital death in this population (higher values associated with higher probability), derived from large retrospective single-center cohort, with external validation. The PREDICT VV-ECMO score suggests favourable performance in predicting hospital mortality under ongoing ECMO. ASAIO Journal 🖇️ https://bit.ly/3MvS4on

Exploring clinical patterns in COVID-19 hospitalized asthma patients using nationwide database data: an observational study. Discover more at https://bit.ly/3InKycw #Asthma #COVID19